Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Biomolecular Life Holdings, Inc. Reaches Another Milestone as It Prepares to Acquire Dr Dacon Medicina Biológica SAS, the Medical Practice of Dr. David Contreras

      • MEXICO - Spanish
      BIOM logo

      News provided by

      Biomolecular Life Holdings Inc

      Nov 17, 2026, 08:00 ET

      Share this article

      Share this article


      The planned acquisition would bring an established biomolecular therapy practice, led by a  renowned physician and expert in biomolecular therapy, and its clinic property in Bogotá's prestigious Santa Bárbara district into BIOM's integrated health and wellness platform.

      MIAMI and BOGOTA, Colombia, Nov. 17, 2026 /PRNewswire/ -- Biomolecular Life Holdings, Inc. (OTC: BIOM), a health and wellness holding company focused on biomolecular nutrition, wellness technologies and longevity-oriented solutions, today announced that it is preparing to acquire Dr Dacon Medicina Biológica SAS ("Dr Dacon"), the Colombian medical practice of Dr. David Contreras, a renowned Colombian physician and expert in biological medicine and biomolecular therapy. The acquisition includes the real estate of the practice's clinic, located in Santa Bárbara, one of Bogotá's most prestigious neighborhoods, directly across from the Fundación Santa Fe de Bogotá University Hospital.

      The planned acquisition marks another milestone in BIOM's strategy to build an integrated biomolecular health platform. It follows the Company's letter of intent to acquire Biomolecular Life LLC, Dr. Contreras's nutritional supplement company for people and pets, and its agreement to acquire land in Llanogrande, Antioquia, for a planned Biomolecular Wellness Spa and Longevity Retreat.

      Upon completion, Dr Dacon would become the Company's clinical arm, providing medical expertise and professional oversight for its biomolecular therapy programs, including those planned for the Llanogrande retreat.

      The Company has signed a non-binding letter of intent to acquire Dr Dacon. The transaction includes both the medical practice and its clinic property. The terms, including the consideration and the valuation of the property by independent appraisal, have not yet been finalized and will be disclosed upon execution of a definitive agreement. Completion is subject to due diligence, a definitive agreement, applicable regulatory requirements and customary closing conditions. Because of Dr. Contreras's relationship with BIOM, the proposed transaction would constitute a related-party transaction.

      Investment Highlights

      Management believes the planned acquisition offers shareholders the following potential advantages:

      • Prime medical real estate included. The acquisition includes the clinic property in Santa Bárbara, one of Bogotá's most prestigious neighborhoods, directly across from the Fundación Santa Fe de Bogotá University Hospital. Owning the property is expected to add a hard asset to the balance sheet and secure a long-term home for the practice in one of the city's leading medical areas.
      • An established clinical practice. Dr Dacon brings an operating medical practice built on more than two decades of clinical work, with patients and professionals from 12 countries, adding medical services to BIOM's product and wellness businesses.
      • Recognized medical leadership. Dr. Contreras trained in biomolecular therapy in Stuttgart, Germany, and conducted cell-reprogramming research at The Hormel Institute, University of Minnesota. His expertise underpins the group's formulations, therapy protocols and planned wellness programs.
      • A vertically integrated model. Together with Biomolecular Pharma's formulations, the Biomolecular Life nutraceutical line and the planned Llanogrande retreat, the practice would connect products, clinical care and hospitality within one group.
      • Additional revenue streams. Medical consultations and biomolecular therapy programs would add service revenue alongside product sales and planned retreat revenue.
      • Exposure to a large, growing market. The Global Wellness Institute values the global wellness economy at $6.8 trillion in 2024 and projects it to reach nearly $9.8 trillion by 2029, growth of about 7.6% a year.
      • A clinical foundation for Llanogrande. The practice is expected to provide the medical team and protocols needed to operate the planned Biomolecular Wellness Spa, targeted to open in the first quarter of 2028.

      About Dr. David Contreras

      Dr. David Contreras is a renowned Colombian physician with extensive experience in biological medicine, biomolecular therapy and regenerative medicine. His career combines clinical practice, academic training, research and social programs in Colombia and internationally, and he currently leads the development and expansion of the Biomolecular Life brand.

      Dr. Contreras began his medical career with the Colombian Battalion No. 3 in the Sinai Peninsula, where he worked in the clinic of the multinational peacekeeping force and took part in medical evacuations. He studied medicine at Nueva Granada Military University, trained in pain management and rehabilitation at the Naval Hospital, treating members of Colombia's Armed Forces injured in the conflict, including landmine survivors, and completed postgraduate studies in homotoxicology at El Bosque University.

      Since 2000 he has worked with international professionals and organizations in biological therapy, including scientific activities with the Sicacell and Sibila laboratories in Europe. In 2010 he trained in biomolecular therapy in Stuttgart, Germany. His research in molecular biology, cell reprogramming and induced pluripotent stem cells (iPSCs) includes work at The Hormel Institute, University of Minnesota, and he contributed to the publication "Cellular Molecular Therapy" in Hong Kong.

      Dr. Contreras has treated and trained patients and professionals from Colombia, Venezuela, Guatemala, Mexico, Costa Rica, Peru, Argentina, Ecuador, Israel, Japan, the United States and Russia. Through Dr Dacon Medicina Biológica SAS, whose clinic is located in Santa Bárbara, Bogotá, across from the Fundación Santa Fe de Bogotá University Hospital, he and his team provide biological and biomolecular medicine services. Through the Da Vida Foundation, he also helps low-income communities access health support programs.

      Building an Integrated Biomolecular Health Platform

      The planned acquisition of Dr Dacon is the latest in a series of steps toward a single platform spanning products, clinical care and wellness hospitality:

      • Letter of intent to acquire Biomolecular Life LLC, Dr. Contreras's nutritional supplement company for people and pets.
      • Agreement to acquire land in Llanogrande, about 10 minutes from José María Córdova International Airport, for a planned Biomolecular Wellness Spa and Longevity Retreat.
      • Planned acquisition of Dr Dacon Medicina Biológica SAS and its clinic property in Santa Bárbara, Bogotá, as the Company's clinical arm.

      Leadership Comments

      "Bringing Dr. Contreras's medical practice into Biomolecular Life Holdings is another important milestone for our Company," said Jessika Wiesner, President and Chief Executive Officer of Biomolecular Life Holdings, Inc.

      "Dr. Contreras is a renowned physician and a leading expert in biomolecular therapy. His practice gives us the clinical foundation to connect our products, our planned wellness destination in Llanogrande and the medical expertise that patients and guests expect."

      "For years, my team and I have focused on helping patients through biomolecular therapy and preventive medicine," said Dr. David Contreras. "Joining Biomolecular Life Holdings will allow us to reach more patients, expand our programs internationally and bring our approach to a platform built for growth."

      About Biomolecular Life Holdings, Inc.

      Biomolecular Life Holdings, Inc. (OTC: BIOM) is a health and wellness holding company focused on biomolecular nutritional products, personalized wellness programs, advanced wellness technologies and longevity-oriented solutions.

      The Company manages the marketing of the Biomolecular Life nutraceutical product line and has signed a letter of intent to acquire Biomolecular Life LLC. It has also agreed to acquire land in Llanogrande, Colombia, for a planned Biomolecular Wellness Spa and Longevity Retreat, and is preparing to acquire Dr Dacon Medicina Biológica SAS, the medical practice of Dr. David Contreras, together with its clinic property in Bogotá.

      For additional information, visit www.biomolecularlifeinc.com

      Forward-Looking Statements
      This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the proposed acquisition of Dr Dacon Medicina Biológica SAS, its timing, terms and expected benefits, the valuation and transfer of the clinic property, the integration of the practice, future revenue, and the Company's other planned acquisitions and projects.

      These statements reflect management's current expectations and are subject to risks and uncertainties, including the negotiation and execution of a definitive agreement, the results of due diligence, the satisfaction of closing conditions, regulatory and licensing requirements applicable to medical practices in Colombia, the ability to integrate the practice and retain key personnel, the availability of financing, market conditions and other factors that could cause actual results to differ materially from those expressed or implied.

      The Company undertakes no obligation to update or revise forward-looking statements except as required by applicable law.

      Media and Investor Relations Contact
      Biomolecular Life Holdings, Inc.
      1395 Brickell Ave., Suite 800
      Miami, FL 33131
      Email: [email protected]
      Phone: 877-646-4833
      Website: www.biomolecularlifeinc.com
      OTC: BIOM

      SOURCE Biomolecular Life Holdings Inc

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.